Role of chymase in blood pressure control, plasma and tissue angiotensin II, renal Haemodynamics, and excretion in spontaneously hypertensive rats

References

• Ghazi L, Drawz P Advances in understanding the Renin-Angiotensin-Aldosterone System (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy. F1000Research. 2017;6:1–10.
   Google Scholar
• Ploth DW.Angiotensin-dependent renal mechanisms in two-kidney, one-clip renal vascular hypertension. Am J Physiol. 1983;245(2):F131–41. doi:10.1152/ajprenal.1983.245.2.F131.
   PubMedGoogle Scholar
• Uehara Y, Miura S, Yahiro E, Saku K. Non-ACE pathway-induced angiotensin II production. Curr Pharm Des [Internet]. 2013;19(17):3054–59. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23176219
   PubMed Web of Science ®Google Scholar
• De Mello WC, Danser AH. Angiotensin II and the heart : on the intracrine renin-angiotensin system. Hypertension [Internet]. 2000;35(6):1183–88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10720595%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/10856260
   PubMed Web of Science ®Google Scholar
• Vajapey R, Rini D, Walston J, Abadir P.The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance. Front Physiol. 2014;5(Nov):1–17.
   PubMedGoogle Scholar
• Pernomian L, Pernomian L, Restini CB.Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications. VASA Eur J Vasc Med. 2014;41(6):404–14.
   Google Scholar
• Ahmad S, Varagic J, Groban L, Dell’Italia LJ, Nagata S, Kon ND, Ferrario CM. Angiotensin-(1–12): a chymase-mediated cellular angiotensin II substrate. Vol. 16, Current Hypertension Reports. 2014.
   Google Scholar
• Kirimura K, Takai S, Jin D, Muramatsu M, Kishi K, Yoshikawa K, Nakabayashi M, Mino Y, Miyazaki M. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats. Hypertens Res. 2005;28(5):457–64. doi:10.1291/hypres.28.457.
   PubMed Web of Science ®Google Scholar
• Roszkowska-Chojecka MM, Walkowska A, Gawrys O, Baranowska I, Kalisz M, Litwiniuk A, Martyńska L, Kompanowska-Jezierska E. Effects of chymostatin, a chymase inhibitor, on blood pressure, plasma and tissue angiotensin II, renal haemodynamics and renal excretion in two models of hypertension in the rat. Exp Physiol [Internet]. 2015;100(9):1093–105. doi:10.1113/EP085325
   PubMed Web of Science ®Google Scholar
• Froogh G, Pinto JT, Le Y, Kandhi S, Aleligne Y, Huang A, Sun D. Chymase-dependent production of angiotensin II: an old enzyme in old hearts. Am J Physiol - Hear Circ Physiol. 2017;312(2):H223–31. doi:10.1152/ajpheart.00534.2016.
   PubMed Web of Science ®Google Scholar
• McDonald JE, Padmanabhan N, Petrie MC, Hillier C, Connell JMC, McMurray JJV. Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro11D-Ala12] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ACE production of angiotensin II in humans. Circulation [Internet]. 2001;104(15):1805–08. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L32963346
   PubMed Web of Science ®Google Scholar
• Paula CA, Sousa MV, Salgado MCO, Oliveira EB.Purification and substrate specificity of an angiotensin converting elastase-2 from the rat mesenteric arterial bed perfusate. Biochim Biophys Acta - Protein Struct Mol Enzymol. 1998;1388(1):227–38.doi:10.1016/S0167-4838(98)00186-1.
   PubMedGoogle Scholar
• Santos CF, Caprio MAV, Oliveira EB, Salgado MCO, Schippers DN, Munzenmaier DH, Greene AS. Functional role, cellular source, and tissue distribution of rat elastase-2, an angiotensin II-forming enzyme. Am J Physiol Heart Circ Physiol. 2003;285(2):H775–83. doi:10.1152/ajpheart.00818.2002.
   PubMed Web of Science ®Google Scholar
• Takai S, Jin D, Muramatsu M, Miyazaki M Chymase as a novel target for the prevention of vascular diseases. Vol. 25, Trends in Pharmacological Sciences. 2004. p. 518–22.
   Google Scholar
• Urata H. Pathological involvement of chymase-dependent angiotensin II formation in the development of cardiovascular disease. J Renin Angiotensin Aldosterone Syst [Internet]. 2000;1(2 Suppl):S35–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17199219
   PubMedGoogle Scholar
• Nolin TD, Colaizzi IV, Palevsky PM, Matzke GR, Frye RF.Rapid microtiter plate assay for determination of inulin in human plasma and dialysate. J Pharm Biomed Anal. 2002;28(2):209–15.doi:10.1016/S0731-7085(01)00643-4.
   PubMed Web of Science ®Google Scholar
• Gawrys O, Baranowska I, Gawarecka K, Swiezewska E, Dyniewicz J, Olszynski KH, Masnyk M, Chmielewski M, Kompanowska-Jezierska E. Innovative lipid-based carriers containing cationic derivatives of polyisoprenoid alcohols augment the antihypertensive effectiveness of candesartan in spontaneously hypertensive rats. Hypertens Res. 2018;41(4):234–45. doi:10.1038/s41440-018-0011-y.
   PubMed Web of Science ®Google Scholar
• Bądzyńska B, Baranowska I, Gawrys O, Sadowski J.Evidence against a crucial role of renal medullary perfusion in blood pressure control of hypertensive rats. J Physiol. 2019;597(1):211–23. doi:10.1113/JP276342.
   PubMed Web of Science ®Google Scholar
• De Godoy MAF, Rattan S. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats. J Pharmacol Exp Ther [Internet]. 2006;318(2):725–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16648368
   PubMed Web of Science ®Google Scholar
• Chandrasekharan UM, Sanker S, Glynias MJ, Karnik SS, Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science. 1996;271(5248):502–05. (80-). doi:10.1126/science.271.5248.502.
   PubMed Web of Science ®Google Scholar
• Pitts LH, Young AR, McCulloch J, MacKenzie E. Vasomotor effects of dimethyl sulfoxide on cat cerebral arteries in vitro and in vivo. Stroke [Internet]. 1986;17(3):483–87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3715947
   PubMedGoogle Scholar
• Kassell N, Sprowell J, Boarini D, Olin J.Effect of dimethyl sulfoxide on the cerebral and systemic circulations of the dog. Neurosurgery. 1983;12(1):24–28. doi:10.1227/00006123-198301000-00005.
   PubMedGoogle Scholar
• Crawford C, Wildman SSP, Kelly MC, Kennedy-Lydon TM, Peppiatt-Wildman CM. Sympathetic nerve-derived ATP regulates renal medullary vasa recta diameter via pericyte cells: a role for regulating medullary blood flow?. Front Physiol. 2013;4:307. doi:10.3389/fphys.2013.00307.
   PubMedGoogle Scholar
• Kim J, Pannabecker TL.Two-compartment model of inner medullary vasculature supports dual modes of vasopressin-regulated inner medullary blood flow. Am J Physiol - Ren Physiol. 2010;299(1):F273–F279. doi:10.1152/ajprenal.00072.2010.
   PubMed Web of Science ®Google Scholar
• Evans KK, Nawata CM, Pannabecker TL.Isolation and perfusion of rat inner medullary vasa recta. Am J Physiol - Ren Physiol. 2015;309(4):F300–4. doi:10.1152/ajprenal.00214.2015.
   PubMed Web of Science ®Google Scholar
• Becari C, Teixeira FR, Oliveira EB, Salgado MCO.Angiotensin-converting enzyme inhibition augments the expression of rat elastase-2, an angiotensin II-forming enzyme. Am J Physiol Heart Circ Physiol. 2011;301(2):H565–70. doi:10.1152/ajpheart.00534.2010.
   PubMed Web of Science ®Google Scholar
• Wintroub BU, Schechter NB, Lazarus GS, Kaempfer CE, Schwartz LB.Angiotensin I conversion by human and rat chymotryptic proteinases. J Invest Dermatol. 1984;83(5):336–39. doi:10.1111/1523-1747.ep12264144.
   PubMed Web of Science ®Google Scholar
• Le Trong H, Neurath H, Woodbury RG. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells. Proc Natl Acad Sci [Internet]. 1987;84(2):364–67. Available from: http://www.pnas.org/content/84/2/364.short
   PubMed Web of Science ®Google Scholar
• Shiota N, Rysä J, Kovanen PT, Ruskoaho H, Kokkonen JO, Lindstedt KA. A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens [Internet]. 2003;21(10):1935–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14508201
   PubMed Web of Science ®Google Scholar
• Kokkonen JO, Lindstedt KA, Kovanen PT.Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms? Circulation. 2003;107(20):2522–24. doi:10.1161/01.CIR.0000074786.92067.AA.
   PubMed Web of Science ®Google Scholar
• Chrysohoou C, Pitsavos C, Barbetseas J, Kotroyiannis I, Brili S, Vasiliadou K, Papadimitriou L, Stefanadis C. Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (hellenic heart failure study). Heart Vessels [Internet]. 2009;24(1):22–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19165564
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Ahmad S, Nagata S, Simington SW, Varagic J, Kon N, Dell’Italia L. An evolving story of angiotensin-II-forming pathways in rodents and humans. Clin Sci. 2014;126(7):461–69. doi:10.1042/CS20130400.
   PubMed Web of Science ®Google Scholar
• Wang T, Han S-X, Zhang S-F, Ning -Y-Y, Chen L, Chen Y-J, He G-M, Xu D, An J, Yang T, et al. Role of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary hypertension in hamsters. Respir Res [Internet]. 2010;11(1):36. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2853423&tool=pmcentrez&rendertype=abstract
   PubMedGoogle Scholar
• Davis GK, Roberts DH.Molecular genetics of the renin-angiotensin system: implications for angiotensin II receptor blockade. Pharmacol Ther. 1997;75(1):43–50. doi:10.1016/S0163-7258(97)00021-1.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Wei CC, Tallaj J, Dell’Italia LJ, Moniwa N, Varagic J, Ferrario CM. Chymase mediates angiotensin-(1-12) metabolism in normal human hearts. J Am Soc Hypertens. 2013;7(2):128–36. doi:10.1016/j.jash.2012.12.003.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Varagic J, VonCannon JL, Groban L, Collawn JF, Dell’Italia LJ, Ferrario CM. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme. Biochem Biophys Res Commun. 2016;478(2):559–64. doi:10.1016/j.bbrc.2016.07.100.
   PubMed Web of Science ®Google Scholar
• Doggrell SA, Wanstall JC Vascular chymase: pathophysiological role and therapeutic potential of inhibition. Vol. 61, Cardiovascular Research. 2004. p. 653–62.
   Google Scholar
• Lorenz JN.Chymase: the other ACE? Am J Physiol Ren Physiol. 2010;298(1):F35–F36. doi:10.1152/ajprenal.00641.2009.
   PubMed Web of Science ®Google Scholar
• Petrie MC, Padmanabhan N, McDonald JE, Hillier C, Connell JMC, McMurray JJV. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol [Internet]. 2001;37(4):1056–61. doi:10.1016/S0735-1097(01)01111-1.
   PubMed Web of Science ®Google Scholar